Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    Start here
    Services
    • FDA Premarket Cybersecurity Package
    • eSTAR Cybersecurity Documentation Support
    • Medical Device Penetration Testing
    • Medical Device Threat Modeling
    • FDA Deficiency Response
    • FDA Postmarket Cybersecurity
    • MedTech Compliance Bundle
    See all services
    Products

    Blue Goat products

    • GoatWatch logoGoatWatchSBOM risk management for medical devices
    About
    Resources

    Learn

    • Blog
    • Podcast
    • Webinars
    • Talks & workshops
    • Glossary
    • FAQs

    Playbooks & Tools

    • Guides
    • Playbooks (PDF)
    • Infographics
    • Interactive Tools

    Signals & Proof

    • Goat FeedNew
    • News
    • Medical Device Security News
    • The Goat's Weekly
    • Case Studies
    • Proof / Receipts
    All resources, topic hubs, & collections →
    ⌘K
    Book Strategy SessionHow to prepare →
    Blue Goat Cyber

    Full-service medical device cybersecurity. We protect patients by securing connected medical devices from design through postmarket.

    275+ FDA submissions supported, zero cybersecurity rejections · Mission: 1,000 by 2028

    SDVOSB · Service-Disabled Veteran-Owned Small Business

    We sponsor 10 community projects →

    Services

    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing
    • FDA Postmarket Cybersecurity
    • All services →
    Services
    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing
    • FDA Postmarket Cybersecurity
    • All services →

    Company

    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF
    Company
    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF

    Resources

    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →
    Resources
    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →

    Get in touch

    • info@bluegoatcyber.com
    • 844-939-GOAT
    • Book a strategy session →
    • 1776 N Scottsdale Rd, Unit 727
      Scottsdale, AZ 85257Serving clients worldwide

    Follow

    © 2026 Blue Goat Cyber. All rights reserved.

    • Privacy
    • Terms
    • Cookies
    • Sitemap
    • Accessibility
    • CVD

    MedTech Cybersecurity · Since 2022

    6-domain SPDF audit

    SPDF Gap Checker

    The February 3, 2026 guidance encourages an SPDF but permits other QMSR approaches. These company checklist scores are not FDA compliance or review outcomes; AI lifecycle draft proposals are not mandatory.

    Christian Espinosa, Founder & CEO, Blue Goat Cyber

    Reviewed by

    Christian Espinosa

    Founder & CEO, Blue Goat Cyber

    Last reviewed October 30, 2026

    Security Risk Management Governance

    Security risk integrated into the QMS, with accountable roles and policy approvals.

    Documented product cybersecurity policy approved by senior management

    Sets scope, roles, escalation, and review cadence.

    Named product security owner per product line

    A single accountable person, not a committee.

    Cyber requirements traceable in design inputs / design outputs

    QMSR incorporates ISO 13485, including applicable design and development controls in §7.3; former §820.30 is not a current QMSR section.

    Annual secure-development training for engineering

    Recorded, role-specific.

    Secure Design & Architecture

    Cyber controls baked in, not bolted on.

    Living threat model (STRIDE / SW96) linked to architecture

    Updated on architecture change.

    Documented trust boundaries and data-flow diagram

    Provide diagrams and explanatory text; DFDs, state diagrams, swim-lane diagrams, and call-flow diagrams are valid options.

    Secure-by-default configuration baseline

    No default credentials, services off by default.

    Cryptography per FIPS 140-3 / NIST SP 800-131A

    Approved algorithms, validated modules where applicable.

    Identity, authentication, and least-privilege model

    Per IEC 81001-5-1 §5.

    Secure Implementation

    Build the thing the design called for, with controls reviewers can verify.

    SAST + secrets scanning in CI on every PR

    Blocking, not informational.

    SBOM generated each build (SPDX or CycloneDX)

    Build-traceable, not periodic.

    SCA + CVE / KEV correlation against SBOM

    Daily or per-build.

    Code-signing and verified / measured boot

    Where the hardware supports it.

    AI-generated code tracked, reviewed, and provenance-logged

    Company supply-chain practice; the February 2026 guidance does not prescribe AI-origin tags or a provenance format.

    Verification & Validation

    Security testing tied back to threat-model items.

    Independent penetration test scoped from the threat model

    Not a one-off scan.

    Protocol / interface fuzzing on exposed surfaces

    Wi-Fi, BLE, USB, vendor APIs.

    Test → threat → control → requirement traceability

    Reviewers will look for it.

    Security regression tests in CI

    Re-run on every release.

    Postmarket Vulnerability Management

    For covered cyber-device submissions, Section 524B requires a vulnerability plan, coordinated disclosure, and cybersecurity processes and patches. The checklist's monitoring and management cadences are company practices, not universal FDA deadlines.

    Published CVD policy with SLAs

    ISO/IEC 29147-aligned.

    Continuous SBOM monitoring + triage workflow

    Documented intake → triage → fix.

    Patch / OTA mechanism validated for the device

    Signed, rollback-safe, integrity-checked.

    21 CFR 806 / FDA postmarket reporting playbook

    Assess applicable reporting triggers separately. The 2016 guidance's 30/60-day policy is conditional reporting-enforcement discretion, not a universal patch deadline. Section 524B requires critical vulnerabilities that could cause uncontrolled risks to be addressed as soon as possible out of cycle.

    Postmarket security metrics reviewed quarterly with management

    MTTR, KEV exposure, patch coverage.

    Supply Chain & Component Risk

    What enters the build is as important as what you write.

    Vendor / component security questionnaire on critical dependencies

    Including AI training-data provenance.

    Build provenance (SLSA L2+ or equivalent)

    Company supply-chain practice; no SLSA level or named attestation format is prescribed by the February 2026 guidance.

    Dependency-confusion + typosquat defenses

    Private registry pinning.

    End-of-support roadmap for OS / chipsets

    Pre-EoL replacement plan exists.

    What you'll see after you submit

    Six SPDF domains scored, with explicit gaps and weighted maturity

    • Governance, secure design, implementation, V&V, postmarket, supply chain - each scored independently.
    • Company-weighted maturity score; weights do not represent FDA review priorities.
    • Domain-by-domain gap list (No = critical, Partial = follow-up) ready to drop into a remediation plan.
    • JSON export for handing to your QMS / GRC system.

    Common misconceptions

    What teams usually get wrong

    • Myth: SPDF is a single document we write before submission.

      Reality: The FDA recommends an SPDF as one way to meet QMSR design-control expectations across the TPLC. If you use one, it operates across engineering, not as a single submission document.

    • Myth: IEC 62304 lifecycle = SPDF.

      Reality: 62304 governs software lifecycle activities; SPDF adds security risk management, threat modeling, postmarket vulnerability handling, and supply-chain controls on top.

    • Myth: If we're 81001-5-1 conformant, the SPDF is done.

      Reality: 81001-5-1 is the strongest single anchor, but the FDA expects integration with QMSR (21 CFR 820), 14971, and the premarket cyber guidance - not 81001-5-1 alone.

    References & further reading

    Primary sources behind this tool

    1. 1FDA Cybersecurity in Medical Devices (Feb 3, 2026 final premarket guidance) - FDA
    2. 2IEC 81001-5-1:2021 - Security activities in the product life cycle - IEC
    3. 3ANSI/AAMI SW96:2023 - Standard for medical device security risk management - AAMI
    4. 421 CFR Part 820 / QMSR (effective Feb 2, 2026) - FDA
    Why this tool is current

    Recent regulatory + supply-chain activity

    Tracked signals that change what reviewers expect. Items move on as new ones land.

    • May 9, 2026FDA

      FDA cybersecurity Q-Submission Q&A series - May 2026 session

    • Mar 31, 2026AAMI

      ANSI/AAMI SW96 Amendment 1 draft circulated for member review

    • Jun 27, 2025FDA

      FDA finalizes 'Cybersecurity in Medical Devices: QMS Considerations and Content of Premarket Submissions'

    Close the gaps

    What plugs into your SPDF.

    Threat Model Starter

    Living STRIDE register that drives V&V scope.

    Read Threat Model Starter

    SBOM Readiness Checker

    Score the supply-chain leg of the framework.

    Read SBOM Readiness Checker

    CVD Policy Generator

    Postmarket disclosure SLA your SPDF references.

    Read CVD Policy Generator

    FDA premarket cybersecurity services

    We stand up the missing pieces with your team.

    Read FDA premarket cybersecurity services